| Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity |
24 |
| Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis |
23 |
| Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance |
13 |
| Refugia and anthelmintic resistance: Concepts and challenges |
12 |
| Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis |
10 |
| Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis |
10 |
| An automated high-throughput system for phenotypic screening of chemical libraries on C. elegans and parasitic nematodes |
10 |
| The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014 |
10 |
| Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis |
10 |
| Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs |
9 |
| High-resolution melt (HRM) analysis for detection of SNPs associated with pyrethroid resistance in the southern cattle fever tick, Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) |
9 |
| In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series |
9 |
| Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis |
8 |
| High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms |
8 |
| Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome (R) and AmBisome (R) in murine cutaneous leishmaniasis |
8 |
| Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine |
8 |
| Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics |
8 |
| Assessment of Draxxin (R) (tulathromycin) as an inhibitor of in vitro growth of Babesia bovis, Babesia bigemina and Theileria equi |
7 |
| Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs |
7 |
| 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice |
7 |
| Similarities and differences in the biotransformation and transcriptomic responses of Caenorhabditis elegans and Haemonchus contortus to five different benzimidazole drugs |
7 |
| Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni |
6 |
| Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites |
6 |
| In vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations |
6 |
| Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites |
6 |
| Physiological aspects of nitro drug resistance in Giardia lamblia |
6 |
| Resistance of Leishmania infantum to allopurinol is associated with chromosome and gene copy number variations including decrease in the S-adenosylmethionine synthetase (METK) gene copy number |
6 |
| UDP-glycosyltransferase family in Haemonchus contortus: Phylogenetic analysis, constitutive expression, sex-differences and resistance-related differences |
6 |
| Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites |
5 |
| Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo |
5 |
| Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis |
5 |
| Modelling anthelmintic resistance by extending eggCounts package to allow individual efficacy |
5 |
| Exploring benzimidazole resistance in Haemonchus contortus by next generation sequencing and droplet digital PCR |
5 |
| Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity |
5 |
| An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni |
5 |
| Terror in the dirt: Sensory determinants of host seeking in soil-transmitted mammalian-parasitic nematodes |
5 |
| Anthelmintic drug actions in resistant and susceptible C-elegans revealed by electrophysiological recordings in a multichannel microfluidic device |
5 |
| Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites |
5 |
| Structural model, functional modulation by ivermectin and tissue localization of Haemonchus contortus P-glycoprotein-13 |
5 |
| Insights into Chagas treatment based on the potential of bacteriocin AS-48 |
5 |
| Managing anthelmintic resistance in cyathostomin parasites: Investigating the benefits of refugia-based strategies |
5 |
| Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB |
4 |
| Identification of plicamycin, TG panobinostat, lestaurtinib, and GDC-0084 as promising compounds for the treatment of central nervous system infections caused by the free-living amebae Naegleria, Acanthamoeba and Balamuthia |
4 |
| Investigating the function and possible biological role of an acetylcholine-gated chloride channel subunit (ACC-1) from the parasitic nematode Haemonchus contortus |
4 |
| Structure-activity profiling of alkaloid natural product pharmacophores against a Schistosoma serotonin receptor |
4 |
| Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro |
4 |
| Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease |
4 |
| Development of amplicon sequencing for the analysis of benzimidazole resistance allele frequencies in field populations of gastrointestinal nematodes |
4 |
| High level efficacy of lufenuron against sea lice (Lepeophtheirus salmonis) linked to rapid impact on moulting processes |
4 |
| Functional screening of selective mitochondrial inhibitors of Plasmodium |
4 |
